Skip to main content
. 2020 Apr 23;21(8):2983. doi: 10.3390/ijms21082983

Figure 2.

Figure 2

Survival curves of MDA-MB-231 and A549 cells exposed to CA-IX pharmacological inhibitors. MDA-MB-231 (A,B) and A549 (C,D) were treated with increasing concentrations [10–300 µM] of SLC-0111 and AA-06-05for 48 h, under experimental condition of medium with 1% FBS. Survival data were calculated as 540 nm relative absorbance/well. Data in the graphs are reported as fold change (means ± SD), giving 100% to the control condition of 1 % serum. (n = 3). * p < 0.05, ** p < 0.01 vs. untreated cells.